VICKI BRALOW: Open Payments
NPI 1962588335 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 56 payments from 15 companies in 2025. Trend: 2023 $1,085 · 2024 $876 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $209 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $162 |
| Lilly USA, LLC | 8 | $156 |
| ABBVIE INC. | 6 | $140 |
| Astellas Pharma US Inc | 6 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| PFIZER INC. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Exact Sciences Corporation | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
Products named: Kerendia, MOUNJARO, VRAYLAR, Veozah, Wegovy, NURTEC ODT, JARDIANCE, XIFAXAN.
Industry payments across PA — which companies pay providers there.
